C
Christine Breynaert
Researcher at Katholieke Universiteit Leuven
Publications - 81
Citations - 1685
Christine Breynaert is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Medicine & Inflammation. The author has an hindex of 18, co-authored 63 publications receiving 1143 citations. Previous affiliations of Christine Breynaert include Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD
Giovanni Latella,Gerhard Rogler,Giorgos Bamias,Christine Breynaert,Jon Florholmen,Gianluca Pellino,Shimon Reif,Silvia Speca,Ian C. Lawrance,Ian C. Lawrance +9 more
TL;DR: The objective was to better understand the pathophysiological mechanisms of intestinal fibrosis, to identify useful markers and imaging modalities of fibrosis in order to assess its presence and progression, and, finally, to point out possible approaches for the prevention and the treatment of Fibrosis.
Journal ArticleDOI
Cellular and Molecular Mediators of Intestinal Fibrosis.
Ian C. Lawrance,Ian C. Lawrance,Gerhard Rogler,Giorgos Bamias,Christine Breynaert,Jon Florholmen,Gianluca Pellino,Shimon Reif,Silvia Speca,Giovanni Latella +9 more
TL;DR: The aim is to heighten the understanding of the factors involved in intestinal fibrogenesis so that detailed research can be encouraged in order to advance the processes that could lead to effective treatments.
Journal ArticleDOI
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease
David Drobne,Peter Bossuyt,Christine Breynaert,Tom Cattaert,Niels Vande Casteele,Griet Compernolle,Matthias Jürgens,Marc Ferrante,Vera Ballet,Willem-Jan Wollants,Isabelle Cleynen,Kristel Van Steen,Ann Gils,Paul Rutgeerts,Severine Vermeire,Gert Van Assche +15 more
TL;DR: It is confirmed that withdrawal of immunomodulators after at least 6 months (median, 13 months) of co-treatment with inflIXimab does not reduce the trough levels of infliximab in patients with Crohn's disease.
Journal ArticleDOI
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.
Lore Vanderbeke,Isabel Spriet,Christine Breynaert,Bart J. A. Rijnders,Paul E. Verweij,Joost Wauters +5 more
TL;DR: In light of the frequency, morbidity and mortality associated with influenza-associated aspergillosis in the ICU, a high awareness of the diagnosis and prompt initiation of antifungal therapy is required.
Journal ArticleDOI
Local immune response to food antigens drives meal-induced abdominal pain
Javier Aguilera-Lizarraga,Morgane Florens,Maria Francesca Viola,Piyush Jain,Lisse Decraecker,Iris Appeltans,Maria Cuende-Estevez,Naomi Fabre,Kim Van Beek,Eluisa Perna,Dafne Balemans,Nathalie Stakenborg,Stavroula Theofanous,Goele Bosmans,Stephanie Mondelaers,Gianluca Matteoli,Sales Ibiza Martínez,Sales Ibiza Martínez,Cintya Lopez-Lopez,Josue Jaramillo-Polanco,Karel Talavera,Yeranddy A. Alpizar,Thorsten B. Feyerabend,Hans-Reimer Rodewald,Ricard Farré,Frank A. Redegeld,Jiyeon Si,Jeroen Raes,Christine Breynaert,Rik Schrijvers,Cedric Bosteels,Bart N. Lambrecht,Bart N. Lambrecht,Scott D. Boyd,Ramona A. Hoh,Deirdre Cabooter,Maxim Nelis,Patrick Augustijns,Sven Hendrix,Jessica Strid,Raf Bisschops,David E. Reed,Stephen Vanner,Alexandre Denadai-Souza,Mira M. Wouters,Guy E. Boeckxstaens +45 more
TL;DR: In this article, the authors identify and characterize a peripheral mechanism that underlies food-induced abdominal pain, thereby creating new possibilities for the treatment of irritable bowel syndrome and related abdominal pain disorders.